Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... of this method by comparing the results obtained with it for 101 tumor samples of neuroblastoma to that obtained by absolute and relative real-time PCR." "Similar ...
2009 NOV 29 ... Awards honoring the agency's development of an awareness campaign for the Children's Neuroblastoma Cancer Foundation.The campaign featured gripping headlines alongside ...
2009 NOV 16 ... of recent studies indicate that expression of TrkB contributes to tumor pathology. In neuroblastoma, TrkA expression marks good prognosis which TrkB and Brain-derived neurotrophic factor ...
2009 NOV 16 ... positive predictive value (PPV) of 100%. Among paediatric patients with a diagnosis of neuroblastoma, an HPC threshold of >16/microl yielded sensitivity and PPV of 100%, while in ...
2009 NOV 29 ... The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online November ...
2009 NOV 16 ... were assayed for inhibition of A beta 42 aggregation. They were also screened in neuroblastoma cell cultures to assess their capacity to inhibit A beta 42 cytotoxicity and evaluated ...
2009 NOV 16 ... for cytochrome c release was analyzed. Data obtained from both rodent and human neuroblastoma cell lines showed that the expression levels of parkin were inversely correlated with ...
2009 NOV 16 ... the potential clinical application of these and additional polyamine depletion agents to neuroblastoma and other advanced cancers in which MYC is operative. (Clin Cancer Res ...
2009 NOV 23 ... on neuronal polarization both in a cell line and in primary neuronal culture. In N2a neuroblastoma cells, SPCA1 was immunocytochemically localized in the juxtanuclear Golgi. Knockdown of ...
2009 NOV 23 ... that nicotine may have protective effects against salsolinol-induced toxicity in human neuroblastoma derived SH-SY5Y cells and that these effects of nicotine are mediated by nicotinic ...
2009 NOV 23 ... "Continuous efforts are dedicated to develop immunotherapeutic approaches to neuroblastoma (NB), a tumor that relapses at high rates following high-dose conventional cytotoxic ...
2009 NOV 9 ... a nutraceutical found in cruciferous vegetables, against many prooxidants in human neuroblastoma cell lines (SH-SY5Y). However, the regulation of the above cellular factors by D3T in ...
2009 NOV 9 ... action of NMDA on St (0.5 mc M)- and salsolinol (250 mc M)-evoked cell death in human neuroblastoma SH-SY5Y cells without its influence on caspase-3 activity, induced by these ...
2009 NOV 16 ... Qingdao, People's Republic of China report. "In this study, we used the neuroblastoma SH-SY5Y cells as an in vitro model to first assess the effect of polypeptide from ...
2009 NOV 16 ... tumor affinity (G2-HD-OEI) to target a N/S-expressing plasmid (CMV-NIS-pcDNA3) to neuroblastoma (Neuro2A) cells. Incubation with NIS-containing polyplexes (G2-HD-OEI/NIS) resulted in a ...
